{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:23:57Z","timestamp":1778199837766,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":1811,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.jvs.2008.02.052","type":"journal-article","created":{"date-parts":[[2008,7,20]],"date-time":"2008-07-20T04:06:42Z","timestamp":1216526802000},"page":"472-477","source":"Crossref","is-referenced-by-count":6,"title":["Superficial femoral artery thrombosis as a cause for distal embolism in primary antiphospholipid syndrome"],"prefix":"10.1016","volume":"48","author":[{"given":"Lannery S.","family":"Lauvao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru R.","family":"Goshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Luis R.","family":"Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul E.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2008.02.052_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jvs.2008.02.052_bib2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005792-198911000-00004","article-title":"The \u201cprimary\u201d antiphospholipid syndrome: major clinical and serological features","volume":"68","author":"Asherson","year":"1989","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jvs.2008.02.052_bib3","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1161\/01.STR.32.8.1701","article-title":"beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the Honolulu heart program","volume":"32","author":"Brey","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.jvs.2008.02.052_bib4","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"Levine","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2008.02.052_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1148\/radiology.202.2.9015050","article-title":"Antiphospholipid syndrome: patterns of life threatening and severe recurrent vascular complications","volume":"202","author":"Insko","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.jvs.2008.02.052_bib6","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1111\/j.1538-7836.2004.00910.x","article-title":"Proposals for the measurement of anti-beta2-glycoprotein I antibodies","volume":"2","author":"Reber","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jvs.2008.02.052_bib7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-0037-1616089","article-title":"Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations\u2013a cooperative project of the European Antiphospholipid Forum","volume":"86","author":"Tincani","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvs.2008.02.052_bib8","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jvs.2008.02.052_bib9","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1056\/NEJMoa035241","article-title":"A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome","volume":"349","author":"Crowther","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2008.02.052_bib10","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jama.295.9.1050","article-title":"Management of antiphospholipid antibody syndrome: a systematic review","volume":"295","author":"Lim","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2008.02.052_bib11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.STR.0000199147.30016.74","volume":"37","author":"Sacco","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.jvs.2008.02.052_bib12","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1111\/j.1538-7836.2006.01961.x","article-title":"Use of fondaparinux in a patient with antiphospholipid antibody syndrome and heparin-associated thrombocytopenia","volume":"4","author":"Holton","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jvs.2008.02.052_bib13","first-page":"ECR32","article-title":"Fondaparinux (ARIXTRA) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins","volume":"88","author":"Parody","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.jvs.2008.02.052_bib14","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1055\/s-0037-1616573","article-title":"Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinux","volume":"93","author":"Kovacs","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvs.2008.02.052_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2249.2004.02497.x","article-title":"Antiphospholipid syndrome: multiple mechanisms","volume":"136","author":"Mackworth-Young","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jvs.2008.02.052_bib16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1182\/blood-2006-04-001206","article-title":"Current concepts on the pathogenesis of the antiphospholipid syndrome","volume":"109","author":"Giannakopoulos","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jvs.2008.02.052_bib17","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.nuclcard.2007.05.003","article-title":"Endothelial dysfunction in patients with antiphospholipid syndrome assessed with positron emission tomography","volume":"14","author":"Alexanderson","year":"2007","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jvs.2008.02.052_bib18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.thromres.2007.04.014","article-title":"Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies","volume":"121","author":"Jy","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvs.2008.02.052_bib19","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/rheumatology\/kem040","article-title":"Vasculopathy and arterial stenotic lesions in the antiphospholipid syndrome","volume":"46","author":"Christodoulou","year":"2007","journal-title":"Rheum"},{"key":"10.1016\/j.jvs.2008.02.052_bib20","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1161\/CIRCULATIONAHA.104.507996","article-title":"Accelerated atherosclerosis in autoimmune rheumatic diseases","volume":"112","author":"Shoenfeld","year":"2005","journal-title":"Circ"},{"key":"10.1016\/j.jvs.2008.02.052_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.thromres.2004.06.027","article-title":"Peripheral vascular disease in antiphospholipid syndrome","volume":"114","author":"Vlachoyiannopoulos","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvs.2008.02.052_bib22","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1002\/art.22663","article-title":"Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals","volume":"56","author":"Erkan","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jvs.2008.02.052_bib23","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1056\/NEJMoa035241","article-title":"A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome","volume":"349","author":"Crowther","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2008.02.052_bib24","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1538-7836.2005.01340.x","article-title":"A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)","volume":"5","author":"Finazzi","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jvs.2008.02.052_bib25","first-page":"2402","article-title":"Primary antiphospholipid syndrome: a 5-year transesophageal echocardiographic followup study","volume":"31","author":"Zavaleta","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jvs.2008.02.052_bib26","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0950-821X(05)80259-2","article-title":"Lower limb ischaemia in primary antiphospholipid syndrome","volume":"7","author":"Nitecki","year":"1993","journal-title":"Eur J Vasc Surg"},{"key":"10.1016\/j.jvs.2008.02.052_bib27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1196\/annals.1422.055","article-title":"Peripheral vascular occlusions leading to gangrene and amputations in antiphospholipid antibody positive patients","volume":"1108","author":"Asherson","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jvs.2008.02.052_bib28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0741-5214(92)70024-F","article-title":"Vascular disease in the antiphospholipid syndrome: a comparison with the patient population with atherosclerosis","volume":"15","author":"Shortell","year":"1992","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2008.02.052_bib29","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/0022-3468(94)90200-3","article-title":"Primary antiphospholipid syndrome in a child with lower extremity arterial thrombosis","volume":"29","author":"Jicha","year":"1994","journal-title":"J Ped Surg"},{"key":"10.1016\/j.jvs.2008.02.052_bib30","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0741-5214(88)90036-5","article-title":"Postoperative thrombotic complications in patients with the lupus anticoagulant: Increased risk after vascular procedures","volume":"7","author":"Ahn","year":"1988","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2008.02.052_bib31","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0741-5214(96)70068-X","article-title":"Prospective comparison of infrainguinal bypass grafting in patients with and without antiphospholipid antibodies","volume":"24","author":"Lee","year":"1996","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2008.02.052_bib32","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1067\/mva.2001.115163","article-title":"Relationship between antiphospholipid antibodies and progression of lower extremity arterial occlusive disease after lower extremity bypass operations","volume":"33","author":"Lam","year":"2001","journal-title":"J Vasc Surg"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521408003054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521408003054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T16:10:52Z","timestamp":1557677452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521408003054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0741521408003054"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2008.02.052","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}